Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

All Approvals
June 2018

This report lists both original approvals and supplemental approvals to NDAs, ANDAs, and BLAs* during the selected month. It includes tentative approvals and original approvals. Supplemental approvals may have occurred after the selected month. This page shows current information for the products listed.

Click on the Application Number to see all drug details, including the full approval history. *Not all biologics are in Drugs@FDA.

This report was produced on June 22, 2018.

 

< Previous Month     Next Month >
Approval Date Drug Name Submission Active Ingredients Company Submission Classification * Submission Status
06/01/2018 NOVOLIN R
NDA #019938		 SUPPL-76 INSULIN RECOMBINANT HUMAN NOVO NORDISK INC Labeling Approval
06/01/2018 NOVOLIN N
NDA #019959		 SUPPL-74 INSULIN SUSP ISOPHANE RECOMBINANT HUMAN NOVO NORDISK INC Labeling Approval
06/01/2018 NOVOLIN N
NDA #019959		 SUPPL-79 INSULIN SUSP ISOPHANE RECOMBINANT HUMAN NOVO NORDISK INC Labeling Approval
06/01/2018 NOVOLIN 70/30
NDA #019991		 SUPPL-75 INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN NOVO NORDISK INC Labeling Approval
06/01/2018 NOVOLIN 70/30
NDA #019991		 SUPPL-79 INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN NOVO NORDISK INC Labeling Approval
06/01/2018 CHANTIX
NDA #021928		 SUPPL-45 VARENICLINE TARTRATE PF PRISM CV Efficacy Approval
06/01/2018 CHANTIX
NDA #021928		 SUPPL-46 VARENICLINE TARTRATE PF PRISM CV Efficacy Approval
06/01/2018 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
ANDA #065443		 SUPPL-13 BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE MYLAN PHARMS INC Manufacturing (CMC) Approval
06/01/2018 LORATADINE
ANDA #075728		 SUPPL-15 LORATADINE PERRIGO Manufacturing (CMC) Approval
06/01/2018 BIVALIRUDIN
ANDA #202471		 ORIG-1 BIVALIRUDIN MYLAN INSTITUTIONAL Approval
06/01/2018 MORPHABOND ER
NDA #206544		 SUPPL-7 MORPHINE SULFATE DAIICHI SANKYO INC Labeling Approval
06/01/2018 NADOLOL
ANDA #210786		 ORIG-1 NADOLOL RICONPHARMA LLC Approval
06/04/2018 ALIMTA
NDA #021462		 SUPPL-51 PEMETREXED DISODIUM LILLY Efficacy Approval
06/04/2018 CLARITIN
NDA #021952		 SUPPL-15 LORATADINE BAYER HEALTHCARE LLC Labeling Approval
06/04/2018 SUPRAX
ANDA #065129		 SUPPL-32 CEFIXIME LUPIN PHARMS Manufacturing (CMC) Approval
06/04/2018 JUXTAPID
NDA #203858		 SUPPL-18 LOMITAPIDE MESYLATE AEGERION REMS Approval
06/04/2018 PREZCOBIX
NDA #205395		 SUPPL-9 COBICISTAT; DARUNAVIR ETHANOLATE JANSSEN PRODS Efficacy Approval
06/04/2018 NICOTINE POLACRILEX
ANDA #208875		 ORIG-1 NICOTINE POLACRILEX WATSON LABS INC Tentative Approval
06/04/2018 TAFLUPROST
ANDA #209040		 ORIG-1 TAFLUPROST SANDOZ INC Tentative Approval
06/04/2018 SUCCINYLCHOLINE CHLORIDE
ANDA #210231		 ORIG-1 SUCCINYLCHOLINE CHLORIDE RENAISSANCE SSA LLC Approval
06/04/2018 FLUOCINONIDE
ANDA #211111		 ORIG-1 FLUOCINONIDE AMNEAL PHARMS LLC Approval
06/04/2018 FULPHILA
BLA #761075		 ORIG-1 PEGFILGRASTIM-JMDB MYLAN GMBH Approval
06/05/2018 NICORETTE
NDA #018612		 SUPPL-80 NICOTINE POLACRILEX GLAXOSMITHKLINE Labeling Approval
06/05/2018 NICORETTE (MINT)
NDA #018612		 SUPPL-80 NICOTINE POLACRILEX GLAXOSMITHKLINE Labeling Approval
06/05/2018 NICORETTE
NDA #020066		 SUPPL-61 NICOTINE POLACRILEX GLAXOSMITHKLINE Labeling Approval
06/05/2018 NICORETTE (MINT)
NDA #020066		 SUPPL-61 NICOTINE POLACRILEX GLAXOSMITHKLINE Labeling Approval
06/05/2018 NICORETTE
NDA #022360		 SUPPL-11 NICOTINE POLACRILEX GLAXOSMITHKLINE CONS Labeling Approval
06/05/2018 MERREM
NDA #050706		 SUPPL-40 MEROPENEM PFIZER Labeling Approval
06/05/2018 OMEPRAZOLE
ANDA #075785		 SUPPL-8 OMEPRAZOLE IMPAX LABS Labeling Approval
06/05/2018 ERBITUX
BLA #125084		 SUPPL-269 CETUXIMAB IMCLONE Approval
06/05/2018 DAPTOMYCIN
ANDA #205037		 ORIG-1 DAPTOMYCIN MYLAN LABS LTD Approval
06/05/2018 FULVESTRANT
ANDA #205935		 ORIG-1 FULVESTRANT SANDOZ INC Tentative Approval
06/05/2018 ALECENSA
NDA #208434		 SUPPL-4 ALECTINIB HYDROCHLORIDE HOFFMANN-LA ROCHE Labeling Approval
06/05/2018 CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
ANDA #208683		 ORIG-1 BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE TARO Approval
06/05/2018 HAILEY FE 1.5/30
ANDA #209031		 ORIG-1 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE GLENMARK PHARMS Approval
06/05/2018 HAILEY 1.5/30
ANDA #209297		 ORIG-1 ETHINYL ESTRADIOL; NORETHINDRONE ACETATE GLENMARK PHARMS Approval
06/06/2018 PRED FORTE
NDA #017011		 SUPPL-50 PREDNISOLONE ACETATE ALLERGAN Labeling Approval
06/06/2018 PRED MILD
NDA #017100		 SUPPL-45 PREDNISOLONE ACETATE ALLERGAN Labeling Approval
06/06/2018 COLISTIMETHATE SODIUM
ANDA #064216		 SUPPL-15 COLISTIMETHATE SODIUM X GEN PHARMS Manufacturing (CMC) Approval
06/06/2018 XIAFLEX
BLA #125338		 SUPPL-109 COLLAGENASE CLOSTRIDIUM HISTOLYTICUM AUXILIUM PHARMS Approval
06/06/2018 OMEPRAZOLE MAGNESIUM
ANDA #206877		 ORIG-1 OMEPRAZOLE MAGNESIUM AUROBINDO PHARMA LTD Approval
06/06/2018 LENVIMA
NDA #206947		 SUPPL-8 LENVATINIB MESYLATE EISAI INC Labeling Approval
06/06/2018 NUPLAZID
NDA #207318		 SUPPL-5 PIMAVANSERIN TARTRATE ACADIA PHARMS INC Labeling Approval
06/06/2018 AUSTEDO
NDA #208082		 SUPPL-2 DEUTETRABENAZINE TEVA BRANDED PHARM Labeling Approval
06/07/2018 PREVACID
NDA #020406		 SUPPL-87 LANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 PREVACID
NDA #020406		 SUPPL-88 LANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 ACIPHEX
NDA #020973		 SUPPL-39 RABEPRAZOLE SODIUM EISAI INC Labeling Approval
06/07/2018 PROTONIX
NDA #020987		 SUPPL-54 PANTOPRAZOLE SODIUM WYETH PHARMS INC Labeling Approval
06/07/2018 PROTONIX IV
NDA #020988		 SUPPL-60 PANTOPRAZOLE SODIUM WYETH PHARMS INC Labeling Approval
06/07/2018 NEXIUM
NDA #021153		 SUPPL-53 ESOMEPRAZOLE MAGNESIUM ASTRAZENECA PHARMS Labeling Approval
06/07/2018 PREVACID
NDA #021428		 SUPPL-34 LANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 PREVACID
NDA #021428		 SUPPL-35 LANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 ZEGERID
NDA #021636		 SUPPL-19 OMEPRAZOLE; SODIUM BICARBONATE SANTARUS INC Labeling Approval
06/07/2018 ZEGERID
NDA #021849		 SUPPL-14 OMEPRAZOLE; SODIUM BICARBONATE SANTARUS INC Labeling Approval
06/07/2018 NEXIUM
NDA #021957		 SUPPL-20 ESOMEPRAZOLE MAGNESIUM ASTRAZENECA PHARMS Labeling Approval
06/07/2018 PROTONIX
NDA #022020		 SUPPL-16 PANTOPRAZOLE SODIUM WYETH PHARMS INC Labeling Approval
06/07/2018 PRILOSEC
NDA #022056		 SUPPL-22 OMEPRAZOLE MAGNESIUM COVIS PHARMA BV Labeling Approval
06/07/2018 NEXIUM
NDA #022101		 SUPPL-17 ESOMEPRAZOLE MAGNESIUM ASTRAZENECA PHARMS Labeling Approval
06/07/2018 DEXILANT
NDA #022287		 SUPPL-29 DEXLANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 DEXILANT
NDA #022287		 SUPPL-30 DEXLANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 VIMOVO
NDA #022511		 SUPPL-23 ESOMEPRAZOLE MAGNESIUM; NAPROXEN HORIZON PHARMA USA Labeling Approval
06/07/2018 PRED-G
NDA #050586		 SUPPL-32 GENTAMICIN SULFATE; PREDNISOLONE ACETATE ALLERGAN Labeling Approval
06/07/2018 PRED-G
NDA #050612		 SUPPL-21 GENTAMICIN SULFATE; PREDNISOLONE ACETATE ALLERGAN Labeling Approval
06/07/2018 PREVPAC
NDA #050757		 SUPPL-22 AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE TAKEDA PHARMS USA Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #075347		 SUPPL-24 OMEPRAZOLE ACTAVIS LABS FL INC Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #075410		 SUPPL-57 OMEPRAZOLE LANNETT CO INC Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #075576		 SUPPL-19 OMEPRAZOLE DR REDDYS LABS LTD Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #075757		 SUPPL-49 OMEPRAZOLE SANDOZ Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #075785		 SUPPL-10 OMEPRAZOLE IMPAX LABS Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #075876		 SUPPL-41 OMEPRAZOLE MYLAN Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #076048		 SUPPL-21 OMEPRAZOLE APOTEX Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #076515		 SUPPL-29 OMEPRAZOLE SANDOZ Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #078490		 SUPPL-14 OMEPRAZOLE DR REDDYS LABS LTD Labeling Approval
06/07/2018 ATORVASTATIN CALCIUM
ANDA #090548		 SUPPL-16 ATORVASTATIN CALCIUM APOTEX INC Labeling Approval
06/07/2018 ATORVASTATIN CALCIUM
ANDA #090548		 SUPPL-17 ATORVASTATIN CALCIUM APOTEX INC Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #091352		 SUPPL-12 OMEPRAZOLE ZYDUS PHARMS USA INC Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #091672		 SUPPL-13 OMEPRAZOLE GLENMARK GENERICS Labeling Approval
06/07/2018 RITUXAN
BLA #103705		 SUPPL-5450 RITUXIMAB GENENTECH Approval
06/07/2018 KINERET
BLA #103950		 SUPPL-5182 ANAKINRA BIOVITRUM AB Approval
06/07/2018 MIRCERA
BLA #125164		 SUPPL-78 METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA HOFFMAN-LA ROCHE Approval
06/07/2018 PROLIA
BLA #125320		 SUPPL-191 DENOSUMAB AMGEN Approval
06/07/2018 XGEVA
BLA #125320		 SUPPL-191 DENOSUMAB AMGEN Approval
06/07/2018 ESOMEPRAZOLE STRONTIUM
NDA #202342		 SUPPL-5 ESOMEPRAZOLE STRONTIUM R2 PHARMA LLC Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #202384		 SUPPL-2 OMEPRAZOLE LUPIN LTD Labeling Approval
06/07/2018 KYPROLIS
NDA #202714		 SUPPL-19 CARFILZOMIB ONYX THERAP Efficacy Approval
06/07/2018 OMEPRAZOLE
ANDA #203270		 SUPPL-8 OMEPRAZOLE AUROBINDO PHARMA LTD Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #203481		 SUPPL-1 OMEPRAZOLE BRECKENRIDGE PHARM Labeling Approval
06/07/2018 OMEPRAZOLE
ANDA #204661		 SUPPL-2 OMEPRAZOLE TEVA PHARMS USA Labeling Approval
06/07/2018 ACIPHEX SPRINKLE
NDA #204736		 SUPPL-10 RABEPRAZOLE SODIUM CERECOR INC Labeling Approval
06/07/2018 YOSPRALA
NDA #205103		 SUPPL-4 ASPIRIN; OMEPRAZOLE ARALEZ PHARMS Labeling Approval
06/07/2018 ETODOLAC
ANDA #208834		 ORIG-1 ETODOLAC AMNEAL PHARMS CO Approval
06/08/2018 SPECTAZOLE
NDA #018751		 SUPPL-25 ECONAZOLE NITRATE ALVOGEN MALTA Labeling Approval
06/08/2018 ALEVE
NDA #020204		 SUPPL-55 NAPROXEN SODIUM BAYER Labeling Approval
06/08/2018 GEMZAR
NDA #020509		 SUPPL-80 GEMCITABINE HYDROCHLORIDE LILLY Labeling Approval
06/08/2018 REMODULIN
NDA #021272		 SUPPL-26 TREPROSTINIL UNITED THERAP Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #075689		 SUPPL-20 HALOPERIDOL LACTATE FRESENIUS KABI USA Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #075858		 SUPPL-20 HALOPERIDOL LACTATE WEST-WARD PHARMS INT Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #075858		 SUPPL-21 HALOPERIDOL LACTATE WEST-WARD PHARMS INT Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #076035		 SUPPL-23 HALOPERIDOL LACTATE TEVA PHARMS USA Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #076035		 SUPPL-24 HALOPERIDOL LACTATE TEVA PHARMS USA Labeling Approval
06/08/2018 QUINAPRIL HYDROCHLORIDE
ANDA #076240		 SUPPL-13 QUINAPRIL HYDROCHLORIDE APOTEX INC Labeling Approval
06/08/2018 QUINAPRIL HYDROCHLORIDE
ANDA #076240		 SUPPL-14 QUINAPRIL HYDROCHLORIDE APOTEX INC Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #076774		 SUPPL-4 HALOPERIDOL LACTATE GLAND PHARMA LTD Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #076774		 SUPPL-5 HALOPERIDOL LACTATE GLAND PHARMA LTD Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #076774		 SUPPL-7 HALOPERIDOL LACTATE GLAND PHARMA LTD Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #078347		 SUPPL-7 HALOPERIDOL LACTATE MYLAN LABS LTD Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #078347		 SUPPL-8 HALOPERIDOL LACTATE MYLAN LABS LTD Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #078347		 SUPPL-11 HALOPERIDOL LACTATE MYLAN LABS LTD Labeling Approval
06/08/2018 SECONAL SODIUM
ANDA #086101		 SUPPL-23 SECOBARBITAL SODIUM VALEANT PHARMS NORTH Labeling Approval
06/08/2018 PROMETH VC W/ CODEINE
ANDA #088764		 SUPPL-87 CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #091637		 SUPPL-3 HALOPERIDOL LACTATE SAGENT PHARMS Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #091637		 SUPPL-4 HALOPERIDOL LACTATE SAGENT PHARMS Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #091637		 SUPPL-5 HALOPERIDOL LACTATE SAGENT PHARMS Labeling Approval
06/08/2018 BETASERON
BLA #103471		 SUPPL-5191 INTERFERON BETA-1B BAYER HEALTHCARE PHARMS Approval
06/08/2018 STELARA
BLA #125261		 SUPPL-147 USTEKINUMAB CENTOCOR ORTHO BIOTECH INC Approval
06/08/2018 HALOPERIDOL
ANDA #200742		 SUPPL-3 HALOPERIDOL LACTATE SAGENT PHARMS Labeling Approval
06/08/2018 HALOPERIDOL
ANDA #200742		 SUPPL-4 HALOPERIDOL LACTATE SAGENT PHARMS Labeling Approval
06/08/2018 PROMETHAZINE HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE
ANDA #200963		 SUPPL-3 CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE AMNEAL PHARMS Labeling Approval
06/08/2018 BUPROPION HYDROCHLORIDE
ANDA #203013		 ORIG-1 BUPROPION HYDROCHLORIDE ALEMBIC PHARMS LTD Approval
06/08/2018 GATIFLOXACIN
ANDA #206446		 ORIG-1 GATIFLOXACIN MICRO LABS Approval
06/08/2018 ESMOLOL HYDROCHLORIDE
ANDA #206608		 ORIG-1 ESMOLOL HYDROCHLORIDE MYLAN LABS LTD Approval
06/08/2018 ESMOLOL HYDROCHLORIDE
ANDA #207107		 ORIG-1 ESMOLOL HYDROCHLORIDE SAGENT PHARMS Approval
06/08/2018 DEXAMETHASONE SODIUM PHOSPHATE
ANDA #207521		 ORIG-1 DEXAMETHASONE SODIUM PHOSPHATE SOMERSET THERAPS LLC Approval
06/08/2018 VENCLEXTA
NDA #208573		 SUPPL-4 VENETOCLAX ABBVIE INC Efficacy Approval
06/08/2018 VENCLEXTA
NDA #208573		 SUPPL-5 VENETOCLAX ABBVIE INC Efficacy Approval
06/08/2018 OSELTAMIVIR PHOSPHATE
ANDA #209421		 ORIG-1 OSELTAMIVIR PHOSPHATE STRIDES PHARMA Approval
06/11/2018 ALEVE
NDA #020204		 SUPPL-56 NAPROXEN SODIUM BAYER Labeling Approval
06/11/2018 SUBUTEX
NDA #020732		 SUPPL-19 BUPRENORPHINE HYDROCHLORIDE INDIVIOR INC REMS Approval
06/11/2018 SUBOXONE
NDA #020733		 SUPPL-23 BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE INDIVIOR INC REMS Approval
06/11/2018 SUBOXONE
NDA #022410		 SUPPL-33 BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE INDIVIOR INC REMS Approval
06/11/2018 AZITHROMYCIN
ANDA #065360		 SUPPL-8 AZITHROMYCIN MYLAN Labeling Approval
06/11/2018 CEFTRIAXONE
ANDA #091049		 ORIG-1 CEFTRIAXONE SODIUM SAGENT PHARMS Approval
06/11/2018 SILDENAFIL CITRATE
ANDA #091448		 ORIG-1 SILDENAFIL CITRATE TORRENT PHARMS LTD Approval
06/11/2018 SILDENAFIL CITRATE
ANDA #202659		 ORIG-1 SILDENAFIL CITRATE HETERO LABS LTD V Approval
06/11/2018 SILDENAFIL CITRATE
ANDA #203962		 ORIG-1 SILDENAFIL CITRATE AUROBINDO PHARMA LTD Approval
06/11/2018 SILDENAFIL CITRATE
ANDA #204882		 ORIG-1 SILDENAFIL CITRATE RUBICON RES PVT LTD Approval
06/11/2018 ROPIVACAINE HYDROCHLORIDE
ANDA #206166		 ORIG-1 ROPIVACAINE HYDROCHLORIDE INFORLIFE Approval
06/11/2018 LACTULOSE
ANDA #207786		 ORIG-1 LACTULOSE BIO-PHARM INC Approval
06/11/2018 VYZULTA
NDA #207795		 SUPPL-2 LATANOPROSTENE BUNOD BAUSCH AND LOMB Labeling Approval
06/12/2018 PRILOSEC OTC
NDA #021229		 SUPPL-32 OMEPRAZOLE MAGNESIUM ASTRAZENECA PHARMS Labeling Approval
06/12/2018 KEYTRUDA
BLA #125514		 SUPPL-34 PEMBROLIZUMAB MERCK SHARP DOHME Approval
06/12/2018 GLEOLAN
NDA #208630		 SUPPL-2 AMINOLEVULINIC ACID HYDROCHLORIDE NXDC Labeling Approval
06/12/2018 PAROXETINE HYDROCHLORIDE
ANDA #209293		 ORIG-1 PAROXETINE HYDROCHLORIDE SCIECURE PHARMA INC Approval
06/12/2018 OMEPRAZOLE
NDA #209400		 SUPPL-2 OMEPRAZOLE DEXCEL PHARMA Labeling Approval
06/12/2018 ISOPROTERENOL HYDROCHLORIDE
ANDA #210322		 ORIG-1 ISOPROTERENOL HYDROCHLORIDE CIPLA LTD Approval
06/12/2018 DIFLORASONE DIACETATE
ANDA #210753		 ORIG-1 DIFLORASONE DIACETATE TELIGENT PHARMA INC Approval
06/13/2018 AVASTIN
BLA #125085		 SUPPL-323 BEVACIZUMAB GENENTECH Approval
06/13/2018 KEYTRUDA
BLA #125514		 SUPPL-30 PEMBROLIZUMAB MERCK SHARP DOHME Approval
06/13/2018 CONTRAVE
NDA #200063		 SUPPL-13 BUPROPION HYDROCHLORIDE; NALTREXONE HYDROCHLORIDE OREXIGEN Labeling Approval
06/13/2018 DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM
ANDA #205947		 ORIG-1 DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM LUPIN LTD Approval
06/13/2018 DOXYCYCLINE HYCLATE
ANDA #210527		 ORIG-1 DOXYCYCLINE HYCLATE ALEMBIC PHARMS LTD Approval
06/13/2018 MOXIDECTIN
NDA #210867		 ORIG-1 MOXIDECTIN MEDICINES DEVELOPMENT FOR GLOBAL HEALTH Type 1 - New Molecular Entity Approval
06/14/2018 CIMZIA
BLA #125160		 SUPPL-279 CERTOLIZUMAB PEGOL UCB INC Approval
06/14/2018 STIVARGA
NDA #203085		 SUPPL-8 REGORAFENIB BAYER HLTHCARE Efficacy Approval
06/14/2018 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
ANDA #205299		 ORIG-1 BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DR REDDYS LABS SA Approval
06/14/2018 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
ANDA #205806		 ORIG-1 BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DR REDDYS LABS SA Approval
06/14/2018 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
ANDA #207607		 ORIG-1 BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE MYLAN TECHNOLOGIES Approval
06/14/2018 BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE
ANDA #207607		 SUPPL-1 BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE MYLAN TECHNOLOGIES Labeling Approval
06/14/2018 BUPROPION HYDROCHLORIDE
ANDA #210015		 ORIG-1 BUPROPION HYDROCHLORIDE YICHANG HUMANWELL Approval
06/14/2018 TECENTRIQ
BLA #761034		 SUPPL-8 ATEZOLIZUMAB GENENTECH INC Approval
06/15/2018 DESOGEN
NDA #020071		 SUPPL-23 DESOGESTREL; ETHINYL ESTRADIOL ORGANON USA INC Labeling Approval
06/15/2018 ISENTRESS
NDA #022145		 SUPPL-39 RALTEGRAVIR POTASSIUM MERCK SHARP DOHME Labeling Approval
06/15/2018 ISENTRESS HD
NDA #022145		 SUPPL-39 RALTEGRAVIR POTASSIUM MERCK SHARP DOHME Labeling Approval
06/15/2018 ONFI
NDA #202067		 SUPPL-5 CLOBAZAM LUNDBECK PHARMS LLC Labeling Approval
06/15/2018 ONFI
NDA #203993		 SUPPL-7 CLOBAZAM LUNDBECK PHARMS LLC Labeling Approval
06/15/2018 BENDAMUSTINE HYDROCHLORIDE
ANDA #204086		 ORIG-1 BENDAMUSTINE HYDROCHLORIDE HOSPIRA INC Tentative Approval
06/15/2018 EFAVIRENZ
ANDA #204766		 ORIG-1 EFAVIRENZ CIPLA LTD Approval
06/15/2018 BENDAMUSTINE HYDROCHLORIDE
ANDA #205476		 ORIG-1 BENDAMUSTINE HYDROCHLORIDE INNOPHARMA LICENSING Tentative Approval
06/15/2018 ROPIVACAINE HYDROCHLORIDE
ANDA #207636		 ORIG-1 ROPIVACAINE HYDROCHLORIDE SOMERSET THERAPS LLC Approval
06/15/2018 LYMEPAK
NDA #209844		 ORIG-1 DOXYCYCLINE HYCLATE CHARTWELL PHARMA Type 5 - New Formulation or New Manufacturer Approval
06/15/2018 CLOBETASOL PROPIONATE
ANDA #210034		 ORIG-1 CLOBETASOL PROPIONATE CHEMO RESEARCH SL Approval
06/15/2018 NEOSTIGMINE METHYLSULFATE
ANDA #210051		 ORIG-1 NEOSTIGMINE METHYLSULFATE AMNEAL PHARMS CO Approval
06/18/2018 DICLEGIS
NDA #021876		 SUPPL-13 DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE DUCHESNAY Labeling Approval
06/18/2018 ARGATROBAN IN SODIUM CHLORIDE
NDA #022434		 SUPPL-11 ARGATROBAN EAGLE PHARMS Labeling Approval
06/18/2018 CEFOBID
NDA #050551		 SUPPL-44 CEFOPERAZONE SODIUM PFIZER Labeling Approval
06/18/2018 AZACTAM
NDA #050580		 SUPPL-44 AZTREONAM BRISTOL MYERS SQUIBB Labeling Approval
06/18/2018 AZACTAM IN PLASTIC CONTAINER
NDA #050632		 SUPPL-19 AZTREONAM BRISTOL MYERS SQUIBB Labeling Approval
06/18/2018 NEUPOGEN
BLA #103353		 SUPPL-5194 FILGRASTIM AMGEN Approval
06/18/2018 NEULASTA
BLA #125031		 SUPPL-193 PEGFILGRASTIM AMGEN Approval
06/18/2018 NATEGLINIDE
ANDA #205544		 ORIG-1 NATEGLINIDE INDICUS PHARMA Approval
06/18/2018 FLUCYTOSINE
ANDA #207536		 ORIG-1 FLUCYTOSINE RECIPHARM Approval
06/18/2018 BONJESTA
NDA #209661		 SUPPL-4 DOXYLAMINE SUCCINATE; PYRIDOXINE HYDROCHLORIDE DUCHESNAY Labeling Approval
06/18/2018 ATORVASTATIN CALCIUM
ANDA #209912		 ORIG-1 ATORVASTATIN CALCIUM GRAVITI PHARMS Approval
06/18/2018 ISOPROTERENOL HYDROCHLORIDE
ANDA #210106		 ORIG-1 ISOPROTERENOL HYDROCHLORIDE AMPHASTAR PHARMS INC Approval
06/18/2018 KETOCONAZOLE
ANDA #210457		 ORIG-1 KETOCONAZOLE STRIDES PHARMA Approval
06/18/2018 VERAPAMIL HYDROCHLORIDE
ANDA #211035		 ORIG-1 VERAPAMIL HYDROCHLORIDE SOMERSET THERAPS LLC Approval
06/18/2018 DARZALEX
BLA #761036		 SUPPL-14 DARATUMUMAB JANSSEN BIOTECH Approval
06/19/2018 TOPAMAX
NDA #020505		 SUPPL-58 TOPIRAMATE JANSSEN PHARMS Labeling Approval
06/19/2018 TOPAMAX
NDA #020844		 SUPPL-49 TOPIRAMATE JANSSEN PHARMS Labeling Approval
06/19/2018 TOPAMAX SPRINKLE
NDA #020844		 SUPPL-49 TOPIRAMATE JANSSEN PHARMS Labeling Approval
06/19/2018 PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
ANDA #040151		 SUPPL-19 CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE HI TECH PHARMA Labeling Approval
06/19/2018 PROMETHAZINE WITH CODEINE
ANDA #040650		 SUPPL-22 CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE VINTAGE Labeling Approval
06/19/2018 M-ZOLE 3 COMBINATION PACK
ANDA #074926		 SUPPL-18 MICONAZOLE NITRATE ACTAVIS MID ATLANTIC Labeling Approval
06/19/2018 PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
ANDA #088763		 SUPPL-88 CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE ACTAVIS MID ATLANTIC Labeling Approval
06/19/2018 PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
ANDA #089647		 SUPPL-14 CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE PHARM ASSOC Labeling Approval
06/19/2018 PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
ANDA #089647		 SUPPL-15 CODEINE PHOSPHATE; PROMETHAZINE HYDROCHLORIDE PHARM ASSOC Labeling Approval
06/19/2018 REMICADE
BLA #103772		 SUPPL-5385 INFLIXIMAB CENTOCOR INC Approval
06/19/2018 COSENTYX
BLA #125504		 SUPPL-5 SECUKINUMAB NOVARTIS PHARMS CORP Approval
06/19/2018 KEYTRUDA
BLA #125514		 SUPPL-43 PEMBROLIZUMAB MERCK SHARP DOHME Approval
06/19/2018 PRASUGREL
ANDA #205913		 ORIG-1 PRASUGREL HYDROCHLORIDE AMNEAL PHARMS Approval
06/19/2018 FLUOCINONIDE
ANDA #209030		 ORIG-1 FLUOCINONIDE TELIGENT PHARMA INC Approval
06/19/2018 TESTOSTERONE CYPIONATE
ANDA #210362		 ORIG-1 TESTOSTERONE CYPIONATE CIPLA LTD Approval
06/19/2018 TECENTRIQ
BLA #761034		 SUPPL-10 ATEZOLIZUMAB GENENTECH INC Approval
06/20/2018 EXTINA
NDA #021738		 SUPPL-7 KETOCONAZOLE MYLAN PHARMS INC Labeling Approval
06/20/2018 CLARITIN
NDA #021952		 SUPPL-16 LORATADINE BAYER HEALTHCARE LLC Labeling Approval
06/20/2018 RIVASTIGMINE
ANDA #205622		 ORIG-1 RIVASTIGMINE MYLAN TECHNOLOGIES Approval
06/20/2018 TYMLOS
NDA #208743		 SUPPL-4 ABALOPARATIDE RADIUS HEALTH INC Labeling Approval
06/21/2018 PEPCID
NDA #019462		 SUPPL-39 FAMOTIDINE VALEANT PHARMS NORTH Labeling Approval
06/21/2018 ULTIVA
NDA #020630		 SUPPL-18 REMIFENTANIL HYDROCHLORIDE MYLAN INSTITUTIONAL Labeling Approval
06/21/2018 RELENZA
NDA #021036		 SUPPL-30 ZANAMIVIR GLAXOSMITHKLINE Labeling Approval
06/21/2018 NOCDURNA
NDA #022517		 ORIG-1 DESMOPRESSIN ACETATE FERRING PHARMS INC Type 5 - New Formulation or New Manufacturer Approval
06/21/2018 RYDAPT
NDA #207997		 SUPPL-2 MIDOSTAURIN NOVARTIS PHARMS CORP Labeling Approval
* NDA Submission Classifications
For details, see FDA/CDER MAPP 5018.2
Classification Meaning
Type 1 New molecular entity
Type 2 New active ingredient
Type 3 New dosage form
Type 4 New combination
Type 5 New formulation or other differences
Type 6 New indication or claim, same applicant [no longer used]
Type 7 Previously marketed but without an approved NDA
Type 8 Rx to OTC
Type 9 New indication or claim, drug not to be marketed under type 9 NDA after approval
Type 10 New indication or claim, drug to be marketed under type 10 NDA after approval
Type 1/4 Type 1, New molecular entity, and Type 4, New combination
Type 2/3 Type 2, New active ingredient, and Type 3, New dosage form
Type 2/4 Type 2, New active ingredient and Type 4, New combination
Type 3/4 Type 3, New Dosage Form, and Type 4, New combination

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English